SSI Diagnostica offers a wide range of pneumococcus antisera
Clinical relevance
Serotyping of pneumococci is used for surveillance of serotype distribution in connection with pneumococcal vaccination of both children and adults. Following the introduction of the various vaccines, an increased incidence of serotypes which were not previously so dominant has been observed.
Background
Pneumococcal antisera from SSI Diagnostica are intended for in vitro diagnostic testing in clinical microbiological laboratories, in reference laboratories, and in the pharmaceutical industry for the quality control of vaccines. All antisera are polyclonal and produced by immunising rabbits with well-defined reference strains. The specific pool, group and type antisera are absorbed free of cross-reactions. Factor antisera are absorbed free of cross-reactions within the group.
Competence
Thanks to our many years of experience producing and serotyping pneumococci, we are able to offer reliable advice and serotyping.
Quality
SSI Diagnostica's antisera are high quality, CE-marked and produced in accordance with DS/EN ISO 13485. The shelf life is 4 years from the date of production, and a minimum of 2 years from delivery.
Support
Technical: Enquiries concerning the use of SSI Diagnostica products should be directed to SSI Diagnostica, info@ssidiagnostica.com, fax +45 4829 9179 or tel.: +45 4829 9100.
Links to brochures, catalogue and packaging inserts for the products, can be found under the respective product descriptions.
